Martin Friedlander, MD
Ophthalmology · la Jolla, CANPI 1952318404
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $10,628 with a category attached, or 94.1%. Alcon Research LLC accounts for 94.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $5,062 and has fallen 95.8% since, to $212 in 2025.
Across 19 payments — averaging $559.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$10K
- Alcon$172
- Neurotech Pharmaceuticals, Inc.$147
- Bausch & Lomb Americas Inc.$97
- Sanofi$91
- Oyster Point Pharma, Inc.$45
- plus $76 from 4 others
What the payments were for
- Speaking & faculty fees$10,00094%
- Food & beverage$6116%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 2 | $10,000 |
| Alcon | 2 | $172 |
| Neurotech Pharmaceuticals, Inc. | 3 | $147 |
| Bausch & Lomb Americas Inc. | 5 | $97 |
| Sanofi | 1 | $91 |
| Oyster Point Pharma, Inc. | 2 | $45 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Alimera Sciences, Inc. | 1 | $19 |
| Thea Pharma Inc. | 1 | $18 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,628 in reported general payments places this provider in the 85th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in la Jolla
- Quang Nguyenla Jolla$608K
- Nikolas Londonla Jolla$440K
- Tomas Grippola Jolla$427K
- Don Kikkawala Jolla$350K
- Bobby Kornla Jolla$251K
- Natalie Afsharila Jolla$205K
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.